Close Menu

NEW YORK — Cytek Biosciences said on Tuesday that its portfolio of seven Class I IVD flow cytometry reagents has received approval from the China National Medical Products Administration (NMPA).

According to the Fremont, California-based company, the reagents consist of basic T, B, and NK cell cluster of differentiation markers used for lymphocyte subset detection.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.